440 related articles for article (PubMed ID: 23530504)
1. Network pharmacology strategies toward multi-target anticancer therapies: from computational models to experimental design principles.
Tang J; Aittokallio T
Curr Pharm Des; 2014; 20(1):23-36. PubMed ID: 23530504
[TBL] [Abstract][Full Text] [Related]
2. Target inhibition networks: predicting selective combinations of druggable targets to block cancer survival pathways.
Tang J; Karhinen L; Xu T; Szwajda A; Yadav B; Wennerberg K; Aittokallio T
PLoS Comput Biol; 2013; 9(9):e1003226. PubMed ID: 24068907
[TBL] [Abstract][Full Text] [Related]
3. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
Ravikumar B; Aittokallio T
Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
[TBL] [Abstract][Full Text] [Related]
4. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.
Fang J; Wu Z; Cai C; Wang Q; Tang Y; Cheng F
J Chem Inf Model; 2017 Nov; 57(11):2657-2671. PubMed ID: 28956927
[TBL] [Abstract][Full Text] [Related]
5. In Silico Oncology Drug Repositioning and Polypharmacology.
Cheng F
Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
[TBL] [Abstract][Full Text] [Related]
6. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products.
Kibble M; Saarinen N; Tang J; Wennerberg K; Mäkelä S; Aittokallio T
Nat Prod Rep; 2015 Aug; 32(8):1249-66. PubMed ID: 26030402
[TBL] [Abstract][Full Text] [Related]
7. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [Abstract][Full Text] [Related]
8. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
[TBL] [Abstract][Full Text] [Related]
9. In silico polypharmacology of natural products.
Fang J; Liu C; Wang Q; Lin P; Cheng F
Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
[TBL] [Abstract][Full Text] [Related]
10. Using quantitative systems pharmacology for novel drug discovery.
Pérez-Nueno VI
Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
[TBL] [Abstract][Full Text] [Related]
11. Novel computational approaches to polypharmacology as a means to define responses to individual drugs.
Xie L; Xie L; Kinnings SL; Bourne PE
Annu Rev Pharmacol Toxicol; 2012; 52():361-79. PubMed ID: 22017683
[TBL] [Abstract][Full Text] [Related]
12. Computational Approaches Towards Kinases as Attractive Targets for Anticancer Drug Discovery and Development.
Hameed R; Khan A; Khan S; Perveen S
Anticancer Agents Med Chem; 2019; 19(5):592-598. PubMed ID: 30306880
[TBL] [Abstract][Full Text] [Related]
13. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
14. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology.
Lim H; He D; Qiu Y; Krawczuk P; Sun X; Xie L
PLoS Comput Biol; 2019 Jun; 15(6):e1006619. PubMed ID: 31206508
[TBL] [Abstract][Full Text] [Related]
15. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
16. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
17. Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in Cancer.
Jaiswal A; Yadav B; Wennerberg K; Aittokallio T
Methods Mol Biol; 2019; 1888():205-217. PubMed ID: 30519949
[TBL] [Abstract][Full Text] [Related]
18. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
19. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
Zhang W; Bai Y; Wang Y; Xiao W
Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
[TBL] [Abstract][Full Text] [Related]
20. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
Cichonska A; Rousu J; Aittokallio T
Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]